Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.260
+0.430 (11.23%)
At close: Apr 2, 2025, 4:00 PM
4.270
+0.010 (0.23%)
After-hours: Apr 2, 2025, 6:16 PM EDT

Adverum Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
8976581731,057744
Upgrade
Market Cap Growth
-3.61%31.60%-66.55%-83.65%42.01%275.72%
Upgrade
Enterprise Value
-034-40-38633609
Upgrade
Last Close Price
3.837.535.7917.60108.40115.20
Upgrade
PS Ratio
65.4421.13-23.03-2976.22
Upgrade
PB Ratio
0.550.910.320.552.434.25
Upgrade
P/TBV Ratio
1.010.910.320.552.434.25
Upgrade
EV/Sales Ratio
46.089.58---2437.97
Upgrade
Debt / Equity Ratio
0.510.900.590.330.070.19
Upgrade
Asset Turnover
0.010.02-0.02-0.00
Upgrade
Quick Ratio
5.543.875.7614.5820.598.56
Upgrade
Current Ratio
5.824.135.9114.8820.829.06
Upgrade
Return on Equity (ROE)
-76.26%-88.43%-62.10%-38.78%-38.57%-34.29%
Upgrade
Return on Assets (ROA)
-29.83%-32.14%-25.11%-19.66%-20.90%-19.64%
Upgrade
Return on Capital (ROIC)
-32.51%-34.62%-26.56%-20.51%-21.93%-20.96%
Upgrade
Earnings Yield
-118.12%-154.06%-267.40%-84.25%-11.12%-8.67%
Upgrade
FCF Yield
-108.02%-120.59%-207.48%-71.17%-8.63%-9.20%
Upgrade
Buyback Yield / Dilution
-70.02%-1.58%-1.24%-15.14%-32.83%-4.44%
Upgrade
Updated Nov 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q